-+ 0.00%
-+ 0.00%
-+ 0.00%

QUANTUM BIOPHARMA SIGNS BINDING LETTER OF INTENT WITH ALLUCENT TO CONDUCT PHASE 2 CLINICAL TRIAL IN MULTIPLE SCLEROSIS

Reuters·03/30/2026 11:50:00

Please log in to view news